Lead Pharma, a clinical stage pharmaceutical company, has entered into a collaboration and license agreement with Roche to develop oral small molecules to treat a broad range of immune mediated diseases.   In this single target research collaboration Lead Pharma and Roche will collaborate in research activities up to the selection of a pre-clinical candidate after which Roche will be responsible for further development and global commercialization.   Terms of the Agreement   Under the terms of t...